Another abysmal quarterly i must agree with you both. No urgency for them to conserve cash either which is worrying. I feel fda could be a given considering its held so strongly above cr of 40c for so long. Would think revenue would have grown considerably post pandemic but not the case.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $181.2M | |||
| Open | High | Low | Value | Volume |
| 79.0¢ | 80.0¢ | 77.0¢ | $307.5K | 390.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 296 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| GSS (ASX) Chart |